Global Pharma Healthcare Private Limited — Roxithromycin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Roxithromycin · $135.0K export value · DGFT Verified
Global Pharma Healthcare Private Limited is the #5 Indian exporter of Roxithromycin with $135.0K in export value and 12 verified shipments. Global Pharma Healthcare Private Limited holds a 3.2% market share in Roxithromycin exports across 3 countries. The company exports 6 pharmaceutical products worth $3.2M across 5 therapeutic categories.
Global Pharma Healthcare Private Limited — Roxithromycin Export Profile: Buyers & Destinations
Where Does Global Pharma Healthcare Private Limited Export Roxithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MADAGASCAR | $144.5K | 11 | 77.8% |
| MYANMAR | $26.8K | 3 | 14.4% |
| CAMBODIA | $13.3K | 6 | 7.2% |
| IVORY COAST | $940 | 2 | 0.5% |
| COTE D IVOIRE | $210 | 2 | 0.1% |
Global Pharma Healthcare Private Limited exports Roxithromycin to 5 countries. The largest destination is MADAGASCAR accounting for 77.8% of Global Pharma Healthcare Private Limited's Roxithromycin shipments, followed by MYANMAR (14.4%) and CAMBODIA (7.2%). These destinations reflect Global Pharma Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Roxithromycin from Global Pharma Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OPHAM - ROUTE DIGUE ANDRANOAMBO | MADAGASCAR | $129.0K | 8 |
| NOTIFY PARTY | MYANMAR | $15.1K | 1 |
| TELPHA INC | CAMBODIA | $13.3K | 6 |
| OPHAM ROUTE DIGUE ANDRANOAMBO LALANA | MADAGASCAR | $10.0K | 2 |
| OPHAM -ROUTE DIGUE ANDRANOAMBO | MADAGASCAR | $5.5K | 1 |
| NOUVELLE PSP COTE D IVOIRE | COTE D IVOIRE | $1.1K | 4 |
| GOLDEN SPIRIT TRADING CO., LTD | MYANMAR | $319 | 1 |
Global Pharma Healthcare Private Limited supplies Roxithromycin to 7 buyers globally. The largest buyer is OPHAM - ROUTE DIGUE ANDRANOAMBO (MADAGASCAR), followed by NOTIFY PARTY (MYANMAR) and TELPHA INC (CAMBODIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Roxithromycin Export Value and How Much Does Global Pharma Healthcare Private Limited Contribute?
India exported $2.9M worth of Roxithromycin through 427 shipments from 78 suppliers to 30 countries, serving 125 buyers globally. Global Pharma Healthcare Private Limited contributes $135.0K to this total, accounting for 3.2% of India's Roxithromycin exports. Global Pharma Healthcare Private Limited ships Roxithromycin to 5 countries through 7 buyers.
What Is the Average Shipment Value for Global Pharma Healthcare Private Limited's Roxithromycin Exports?
Global Pharma Healthcare Private Limited's average Roxithromycin shipment value is $11.3K per consignment, based on 12 shipments totaling $135.0K. The largest destination is MADAGASCAR (77.8% of Global Pharma Healthcare Private Limited's Roxithromycin exports).
How Does Global Pharma Healthcare Private Limited Compare to Other Indian Roxithromycin Exporters?
Global Pharma Healthcare Private Limited ranks #5 among 78 Indian Roxithromycin exporters with a 3.2% market share. The top 3 exporters are STRIDES PHARMA SCIENCE LIMITED ($758.8K), BRAWN LABORATORIES LIMITED ($700.0K), MARKSANS PHARMA LIMITED ($598.0K). Global Pharma Healthcare Private Limited processed 12 shipments to 3 destination countries.
What Roxithromycin Formulations Does Global Pharma Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE- ROXITHROMYCIN 150 MG | $129.0K | 8 |
| HARMLESS MEDICINES- ROX-150 ROXITHROMYCIN 150 MG TABLET UNIT-10X10'S QTY-6601. | $15.1K | 1 |
| HARMLESS MEDICINES ROX 150 ROXITHROMYCIN150MG TABLET UNIT- 1X10X10 QTY-1138. | $13.3K | 3 |
| HARMLESS MEDICINES-ROX 150 ROXITHROMYCIN | $11.4K | 1 |
| HARMLESS MEDICINE-ROX 150 ROXITHROMYCIN150 MG TABLET UNIT-1X10'S QTY-10030. | $10.0K | 2 |
| HARMLESS MEDICINESROX 150 ROXITHROMYCIN150 MG TABLET UNIT-11X10'S QTY-11230 .NOS | $5.5K | 1 |
| ROXITHROMYCIN 150 MG TABLET ROX 150 | $940 | 2 |
| HARMLESS MEDICINES - ROX-150 - ROXITHROMYCIN 150 MG TABLET - 10X10`SNOS | $319 | 1 |
| ROXITHROMYCIN 150 MG TABLET ( ROX 150) U | $210 | 2 |
| PHYSICIAN SAMPLE NOT FOR SALE VALUE DECLARED FOR CUSTOMS PURPOSE ONLY.ROX 150 ROXITHROMYCIN 150MG TAB UNIT-1X10X10. | $0 | 3 |
Global Pharma Healthcare Private Limited exports 10 distinct Roxithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE- ROXITHROMYCIN 150 MG with 8 shipments worth $129.0K.
How Does Global Pharma Healthcare Private Limited Compare to Nearest Roxithromycin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MARKSANS PHARMA LIMITED | $598.0K | 15 | 2 | $39.9K |
| 4 | TORRENT PHARMACEUTICALS LTD | $191.6K | 14 | 2 | $13.7K |
| 5 | GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED ★ | $135.0K | 12 | 3 | $11.3K |
| 6 | MICRO LABS LIMITED | $129.4K | 7 | 2 | $18.5K |
| 7 | UMEDICA LABORATORIES PRIVATE LIMITED | $93.2K | 3 | 1 | $31.1K |
Global Pharma Healthcare Private Limited ranks #5 among 78 Indian Roxithromycin exporters. Average shipment value of $11.3K compared to the market average of $36.7K. The closest competitors by value are MARKSANS PHARMA LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Roxithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 64 | 15.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 40 | 9.4% |
| SAHAR AIR | 35 | 8.2% |
| Bombay Air | 29 | 6.8% |
| NHAVA SHEVA SEA (INNSA1) | 25 | 5.9% |
| DELHI AIR | 24 | 5.6% |
| TUGLAKABAD ICD | 14 | 3.3% |
| BANGALORE ICD | 14 | 3.3% |
About Global Pharma Healthcare Private Limited
Global Pharma Healthcare Private Limited exports 6 products worth $3.2M. Beyond Roxithromycin, top products include Prednisolone, Vildagliptin, Empagliflozin, Repaglinide, Probiotics. View the complete Global Pharma Healthcare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Roxithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Roxithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Global Pharma Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 24 individual customs records matching Global Pharma Healthcare Private Limited exporting Roxithromycin, covering 10 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 30+ countries, 125+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Roxithromycin Export Data from Global Pharma Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Global Pharma Healthcare Private Limited's Roxithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Global Pharma Healthcare Private Limited
Full Company Profile →
6 products · $3.2M total trade · 5 categories
Roxithromycin Stats
Company Overview
Top Products by Global Pharma Healthcare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Global Pharma Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Roxithromycin. For current shipment-level data, contact TransData Nexus.